IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

Gökhan S. Hotamışlıgil(Dana-Farber Cancer Institute), Pascal Peraldi(Dana-Farber Cancer Institute), Adriane I. Budavari(Dana-Farber Cancer Institute), Ramsey Ellis(Dana-Farber Cancer Institute), Morris F. White(Joslin Diabetes Center), Bruce M. Spiegelman(Dana-Farber Cancer Institute)
Science
February 2, 1996
Cited by 2,604

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is an important mediator of insulin resistance in obesity and diabetes through its ability to decrease the tyrosine kinase activity of the insulin receptor (IR). Treatment of cultured murine adipocytes with TNF-alpha was shown to induce serine phosphorylation of insulin receptor substrate 1 (IRS-1) and convert IRS-1 into an inhibitor of the IR tyrosine kinase activity in vitro. Myeloid 32D cells, which lack endogenous IRS-1, were resistant to TNF-alpha-mediated inhibition of IR signaling, whereas transfected 32D cells that express IRS-1 were very sensitive to this effect of TNF-alpha. An inhibitory form of IRS-1 was observed in muscle and fat tissues from obese rats. These results indicate that TNF-alpha induces insulin resistance through an unexpected action of IRS-1 to attenuate insulin receptor signaling.


Related Papers

No related papers found

Powered by citation graph analysis